Benjamin Larimer, Ph.D., is an Assistant Professor in the Department of Radiology and an Associate Scientist in the O'Neal Comprehensive Cancer Center at the University of Alabama Birmingham.
He obtained his Ph.D. at the University of Missouri in the lab of Dr. Susan Deutscher studying phage display and trained as a postdoctoral fellow in the lab of Dr. Umar Mahmood at Massachusetts General Hospital and the Harvard Medical School. His lab focuses on the development and utilization of clinically-translatable targeted peptides for the characterization of disease.
His contributions include the discovery of a first-in-class granzyme B PET tracer that is currently being investigated in first-in-human studies. He has been named a Society of Nuclear Medicine Ones to Watch and has won the Alavi-Mandell Award and High Country Nuclear Medicine Young Investigator Award. He is the recipient of the NIH Directors New Innovator Award and the NIH Pathway to Independence Award.
